Comparative Safety of Long-Acting Bronchodilators

Aug-06

AUTHORS : Dr Stephan Lanes (Details for this study: Boehringer Ingelheim), now working at HealthCore, Wilmington Office, 123 Justison Street, Suite 200, Wilmington, DE 19801, United States – Email: slanes@healthcore.com – Profile: https://www.healthcore.com/experts/stephan-lanes-phd-mph/

JOURNAL : Pharmacoepidemiology and Drug Safety

REFERENCE: 15(S1):S75

DOI : 10.1002/pds.1295

Comparative Safety of Long-Acting Bronchodilators

More publications

Characteristics, risk factors and clinical impact of penicillin and other antibiotic allergies in adults in the UK General Practice: a population-based cohort study

Glucose Lowering through Weight management (GLoW): a randomised controlled trial of the clinical and cost effectiveness of a diabetes education and behavioural weight management programme vs a diabetes education programme in adults with a recent diagnosis of type 2 diabetes

Target Serum Urate Achievement and Chronic Kidney Disease Progression in Patients With Gout and Kidney Disease